Entrada Therapeutics, Inc. (TRDA)

Entrada Therapeutics Revenue

Entrada Therapeutics had revenue of $875.00K in the quarter ending March 31, 2026, a decrease of -95.74%. This brings the company's revenue in the last twelve months to $5.74M, down -96.67% year-over-year. In the year 2025, Entrada Therapeutics had annual revenue of $25.42M, down -87.94%.

• Revenue (ttm): $5.74M
• Revenue Growth: -96.67%
• P/S Ratio: 40.25
• Revenue / Employee: $37,750
• Employees: 152
• Market Cap: 221.97M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	25.42M	-185.36M	-87.94%
Dec 31, 2024	210.78M	81.77M	63.38%
Dec 31, 2023	129.01M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: May 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error